Table 3 Performance of the top nine triggers at the six study sites
Trigger typeSite 1Site 2Site 3Site 4Site 5Site 6All sites
TriggersADEs (PPV)TriggersADEs (PPV)TriggersADEs (PPV)TriggersADEs (PPV)TriggersADEs (PPV)TriggersADEs (PPV)TriggersADEs (PPV)
1. Medication stop9114 (15.4%)929 (9.8%)8328 (33.7%)10613 (12.3%)13345 (33.8%)8546 (54.1%)590155 (26.3%)
2. Hospitalisation257 (28.0%)122 (16.7%)61 (16.7%)143 (21.4%)234 (17.4%)215 (23.8%)10122 (21.8%)
3. Emergency-room visit265 (19.2%)221 (4.5%)92 (22.2%)61 (16.7%)143 (21.4%)172 (11.8%)9414 (14.9%)
4. INR>511 (100%)044 (100%)11 (100%)22 (100%)088 (100%)
5. TSH<0.03 on thyroxine22 (100%)11 (100%)011 (100%)33 (100%)32 (66.7%)109 (90%)
6. Creat>2.550 (0%)20 (0%)32 (66.7%)10 (0%)040 (0%)152 (13.3%)
7. BUN>6010 (0%)10 (0%)61 (16.7%)20 (0%050 (0%)151 (6.7%)
8. ALT>8410 (0%)72 (28.6%)0033 (100%)20 (0%)135 (38.5%)
9. AST>8010 (0%)121 (8.3%)0022 (100%)0153 (20%)
Subtotal of above 9 triggers15329 (19.0%)14916 (10.7%)11138 (34.2%)13119 (14.5%)18062 (34.4%)13755 (40.1%)861219 (25.4%)
Subtotal of rest of triggers31 (33.3%)171 (5.9%)104 (40%)30 (0%)84 (50.0%)63 (50.0%)4713 (27.7%)
Total of all triggers15630 (19.2%)16617 (10.2%)12142 (34.7%)13419 (14.8%)18866 (35.1%)14358 (40.6%)908232 (25.5%)
Sensitivity of the top 9 triggers (% of ADEs detected by these)98.1%96.7%89.8%94.1%91.7%90.5%97.8%100%95.7%93.9%95.8%94.8%94.8%94.4%
  • ADE, adverse drug event; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; INR, international normalized ratio; PPV, positive predictive value; TSH, thyroid-stimulating hormone.